SomaLogic, Inc. logo

SomaLogic, Inc.

NASDAQ:SLGC

Overview | Financials
Company Name SomaLogic, Inc.
Symbol SLGC
Currency USD
Price 2.1
Market Cap 396,225,917
Dividend Yield 0%
52-week-range 1.73 - 3.79
Industry Health Information Services
Sector Healthcare
CEO Mr. Adam Taich
Website https://www.somalogic.com

An error occurred while fetching data.

About SomaLogic, Inc.

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification

Related Stocks

Innoviva, Inc. logo

Innoviva, Inc.

INVA

20 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

3.19 USD

Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT

5.63 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

28.44 USD

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

Celularity Inc. logo

Celularity Inc.

CELU

3.09 USD

Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

AGIO

55.08 USD

RadNet, Inc. logo

RadNet, Inc.

RDNT

71.4 USD

Outset Medical, Inc. logo

Outset Medical, Inc.

OM

0.776 USD

Financials

Numbers are in millions USD

Numbers are in millions USD